What the Study Found (In Plain English)
Published in Clinical and experimental dermatology (2025), this randomized controlled trial evaluating 33 human participants investigated: The histological hallmark of male androgenetic alopecia (MAGA) is the transformation of terminal follicles into miniaturized secondary vellus follicles. Key clinical takeaway: The effect of SLM on mean fibre diameter was dose dependent. SLM 1.35 mg and 4.05 mg, but not 0.45 mg, significantly increased mean fibre diameter in MAGA (P < 0.05). The diameter increased most in the intermediate and thickest hairs.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Clinical and experimental dermatology, 2025-06-25; N = 33; Rigor 88/100): The effect of SLM on mean fibre diameter was dose dependent. SLM 1.35 mg and 4.05 mg, but not 0.45 mg, significantly increased mean fibre diameter in MAGA (P < 0.05). The diameter increased most in the intermediate and thickest hairs.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.